Home › Phenylketonuria › Texas › Dallas
Phenylketonuria clinical trials in Dallas, TX
7 studies for Phenylketonuria are looking for participants at sites in and around Dallas (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Immune Modulation During Palynziq® Treatment in Adults (IMPALA)
RecruitingPhase 4
- UT Southwestern Medical Center, Dallas
A Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AG-181 in Subjects With Phenylketonuria
RecruitingPhase 1
- University of Texas Southwestern Medical Center (UTSW), Dallas
A Study of JNT-517 in Participants With Phenylketonuria (PKU)
RecruitingPhase 3
- University of Texas Southwestern, Dallas
AAV Gene Therapy Clinical Study in Adult Classic PKU (PHEdom)
RecruitingPhase 1/2
- University or Texas, Southwestern medical Center, Dallas
A Long-Term Study of JNT-517 in Participants With Phenylketonuria
RecruitingPhase 3
- Children's Medical Center Dallas, Dallas
- University of Texas Southwestern Medical Center, Dallas
A Long-term, Post-marketing Safety Study of Palynziq in Patients With PKU (PALace)
RecruitingObservational study
- University of Texas Southwestern Medical Center, Dallas
A Long Term, Post-marketing Study of Immune Response in Patients Receiving Palynziq Treatment for PKU (PALisade)
RecruitingObservational study
- UT Southwestern Medical Center, Dallas
About Phenylketonuria
In phenylketonuria (PKU), your body can't process phenylalanine, an amino acid in most foods. Read about genetics, screening, and special diets.
More about Phenylketonuria on MedlinePlus
Phenylketonuria trials in other cities
- Pittsburgh, PA7 studies
- Chicago, IL6 studies
- Indianapolis, IN6 studies
- Portland, OR5 studies
- Salt Lake City, UT4 studies
- Atlanta, GA4 studies
- Tampa, FL3 studies
- Boston, MA3 studies
- Milwaukee, WI3 studies
- Aurora, CO3 studies
- Nashville, TN3 studies
Other studies in Dallas
- Breast Cancer54 studies
- Non-Small Cell Lung Cancer53 studies
- Metastatic Cancer44 studies
- Heart Failure42 studies
- Cancer (all types)40 studies
- Prostate Cancer39 studies
- Colorectal Cancer34 studies
- Obesity33 studies
- Ovarian Cancer31 studies
- Bladder Cancer27 studies
- Lung Cancer26 studies
- Endometrial Cancer25 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.